{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:57:37Z","timestamp":1790827057257,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.gim.2025.101480","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T19:53:20Z","timestamp":1753214000000},"page":"101480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Isolated lateralized overgrowth and the need for tumor screening: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"27","author":[{"given":"Angelika L.","family":"Erwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Abu","family":"El Haija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie G.","family":"Biesecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Deardorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan R.","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Martinez-Agosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajhg.2020.11.013","article-title":"A dyadic approach to the delineation of diagnostic entities in clinical genomics","volume":"108","author":"Biesecker","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.a.30729","article-title":"Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis","volume":"136","author":"Rump","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.gim.2025.101480_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cge.14410","article-title":"Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: impact on screening recommendations","volume":"104","author":"Faivre","year":"2023","journal-title":"Clin Genet"},{"key":"10.1016\/j.gim.2025.101480_bib4","series-title":"GeneReviews","article-title":"Proteus syndrome","author":"Biesecker","year":"2012"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-015-3665-z","article-title":"Breast cancer risk and clinical implications for germline PTEN mutation carriers","volume":"165","author":"Ngeow","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.gim.2025.101480_bib6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ajmg.a.38266","article-title":"Nomenclature and definition in asymmetric regional body overgrowth","volume":"173","author":"Kalish","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/GIM.0b013e31819436cf","article-title":"Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia","volume":"11","author":"Clericuzio","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101480_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1382371","article-title":"Molecular mechanisms of human overgrowth and use of omics in its diagnostics: chances and challenges","volume":"15","author":"Prawitt","year":"2024","journal-title":"Front Genet"},{"issue":"11","key":"10.1016\/j.gim.2025.101480_bib9","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41436-020-0877-3","article-title":"A six-attribute classification of genetic mosaicism","volume":"22","author":"Mart\u00ednez-Glez","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101480_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114177","article-title":"Molecular basis and diagnostic approach to isolated and syndromic lateralized overgrowth in childhood","volume":"274","author":"Bellucca","year":"2024","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/cge.13997","article-title":"Isolated- and Beckwith-Wiedemann syndrome related- lateralised overgrowth (hemihypertrophy): clinical and molecular correlations in 94 individuals","volume":"100","author":"Radley","year":"2021","journal-title":"Clin Genet"},{"issue":"13","key":"10.1016\/j.gim.2025.101480_bib12","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","article-title":"Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.gim.2025.101480_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ajmg.a.30327","article-title":"Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases","volume":"130A","author":"Turner","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"10","key":"10.1016\/j.gim.2025.101480_bib14","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/ajmg.a.36080","article-title":"Prevalence of Beckwith-Wiedemann syndrome in North West of Italy","volume":"161A","author":"Mussa","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrendo.2017.166","article-title":"Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement","volume":"14","author":"Brioude","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jmedgenet-2019-106498","article-title":"Improved molecular detection of mosaicism in Beckwith-Wiedemann syndrome","volume":"58","author":"Baker","year":"2021","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2013.132","article-title":"Clinical utility gene card for: Beckwith-Wiedemann syndrome","volume":"22","author":"Eggermann","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gim.2025.101480_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2016.05.038","article-title":"Cancer risk in Beckwith-Wiedemann syndrome: a systematic review and meta-analysis outlining a novel (epi)genotype specific histotype targeted screening protocol","volume":"176","author":"Mussa","year":"2016","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.gim.2025.101480_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.ejhg.5201463","article-title":"Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome","volume":"13","author":"Cooper","year":"2005","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.gim.2025.101480_bib20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/genes12111839","article-title":"Characteristics associated with tumor development in individuals diagnosed with Beckwith-Wiedemann spectrum: novel tumor-(epi)genotype-phenotype associations in the BWSp population","volume":"12","author":"Duffy","year":"2021","journal-title":"Genes (Basel)"},{"issue":"9","key":"10.1016\/j.gim.2025.101480_bib21","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/ajmg.a.37801","article-title":"Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups","volume":"170","author":"Maas","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"23","key":"10.1016\/j.gim.2025.101480_bib22","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1158\/1078-0432.CCR-24-2100","article-title":"Update on surveillance for Wilms tumor and hepatoblastoma in Beckwith-Wiedemann syndrome and other predisposition syndromes","volume":"30","author":"Kalish","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jmg.2004.024646","article-title":"Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations","volume":"42","author":"Butler","year":"2005","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.gim.2025.101480_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.ejhg.5201823","article-title":"Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity","volume":"15","author":"Caux","year":"2007","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.gim.2025.101480_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2133.2007.07818.x","article-title":"Type 2 segmental Cowden disease vs. Proteus syndrome","volume":"156","author":"Happle","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.gim.2025.101480_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cancers11060844","article-title":"PTEN hamartoma tumor syndrome: a clinical overview","volume":"11","author":"Pilarski","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12920-022-01362-1","article-title":"Clinical and genetic analyses of patients with lateralized overgrowth","volume":"15","author":"Kim","year":"2022","journal-title":"BMC Med Genomics"},{"issue":"8","key":"10.1016\/j.gim.2025.101480_bib28","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/hmg\/8.8.1461","article-title":"PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome","volume":"8","author":"Marsh","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.gim.2025.101480_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jmg.36.5.360","article-title":"Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN","volume":"36","author":"Celebi","year":"1999","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.gim.2025.101480_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jmg.2011.088807","article-title":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features","volume":"48","author":"Pilarski","year":"2011","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.gim.2025.101480_bib31","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/1097-0142(197806)41:6<2393::AID-CNCR2820410644>3.0.CO;2-K","article-title":"Cowden\u2019s disease: a cutaneous marker of breast cancer","volume":"41","author":"Brownstein","year":"1978","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.gim.2025.101480_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gim.2025.101480_bib33","series-title":"NCCN Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic","author":"Daly","year":"2024"},{"issue":"12","key":"10.1016\/j.gim.2025.101480_bib34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/gim.2017.65","article-title":"Quantifying survival in patients with Proteus syndrome","volume":"19","author":"Sapp","year":"2017","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajmg.1320570117","article-title":"Neoplasms in Proteus syndrome","volume":"57","author":"Gordon","year":"1995","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.1016\/j.gim.2025.101480_bib36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A mosaic activating mutation in AKT1 associated with the Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.gim.2025.101480_bib37","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","article-title":"Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum","volume":"164A","author":"Keppler-Noreuil","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gim.2025.101480_bib38","series-title":"GeneReviews","article-title":"PIK3CA-related overgrowth spectrum","author":"Mirzaa","year":"2013"},{"issue":"2","key":"10.1016\/j.gim.2025.101480_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.gim.2025.101480_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87623","article-title":"PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution","volume":"1","author":"Mirzaa","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.0.CO;2-V","article-title":"Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities","volume":"70","author":"Moore","year":"1997","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00019605-200207000-00010","article-title":"Atypical macrocephaly-cutis marmorata telangiectatica congenita with retinoblastoma","volume":"11","author":"Schwartz","year":"2002","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.gim.2025.101480_bib43","series-title":"GeneReviews","article-title":"Neurofibromatosis 1","author":"Friedman","year":"1998"},{"issue":"17","key":"10.1016\/j.gim.2025.101480_bib44","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gim.2025.101480_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1750-1172-7-75","article-title":"Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1","volume":"7","author":"Nguyen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-018-0811-9","article-title":"Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1","volume":"13","author":"Sellmer","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.gim.2025.101480_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.gim.2025.101480_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/dmcn.12038","article-title":"Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1","volume":"55","author":"Walsh","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.gim.2025.101480_bib49","series-title":"GeneReviews","article-title":"2-related schwannomatosis","author":"Evans","year":"1998"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151809","article-title":"Metabolic tumour burden measured by 18F-FDG PET\/CT predicts malignant transformation in patients with neurofibromatosis type-1","volume":"11","author":"Van Der Gucht","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","article-title":"A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations","volume":"16","author":"Canaud","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2025.101480_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/bmb\/ldab023","article-title":"Treatment strategies for mosaic overgrowth syndromes of the PI3K-AKT-mTOR pathway","volume":"140","author":"Morin","year":"2021","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jmoldx.2017.04.006","article-title":"Molecular diagnosis of mosaic overgrowth syndromes using a custom-designed next-generation sequencing panel","volume":"19","author":"Chang","year":"2017","journal-title":"J Mol Diagn"},{"issue":"8","key":"10.1016\/j.gim.2025.101480_bib54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/gcc.22739","article-title":"Comprehensive molecular and clinicopathological analysis of vascular malformations: a study of 319 cases","volume":"58","author":"Ten Broek","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.gim.2025.101480_bib55","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/ajmg.a.62241","article-title":"Genetic heterogeneity of disorders with overgrowth and intellectual disability: experience from a center in North India","volume":"185","author":"Moirangthem","year":"2021","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gim.2025.101480_bib56","article-title":"Overgrowth syndromes-evaluation, diagnosis, and management","volume":"8","author":"Manor","year":"2020","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MOP.0000000000000923","article-title":"PIK3CA vascular overgrowth syndromes: an update","volume":"32","author":"Hughes","year":"2020","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"10.1016\/j.gim.2025.101480_bib58","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ng.2332","article-title":"Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA","volume":"44","author":"Lindhurst","year":"2012","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.gim.2025.101480_bib59","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ajmg.a.62126","article-title":"Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys)","volume":"185","author":"Chenbhanich","year":"2021","journal-title":"Am J Med Genet A"},{"issue":"24","key":"10.1016\/j.gim.2025.101480_bib60","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.3390\/cancers13246166","article-title":"Lateralized and segmental overgrowth in children","volume":"13","author":"Mussa","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.536","article-title":"Molecular diagnosis of somatic overgrowth conditions: a single-center experience","volume":"7","author":"Lalonde","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jmoldx.2017.04.001","article-title":"Overgrowth syndromes caused by somatic variants in the phosphatidylinositol 3-kinase\/AKT\/mammalian target of rapamycin pathway","volume":"19","author":"Akgumus","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.gim.2025.101480_bib63","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fped.2019.00562","article-title":"Diagnosis and management of Beckwith-Wiedemann syndrome","volume":"7","author":"Wang","year":"2019","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.gim.2025.101480_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.ejhg.5202001","article-title":"MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment","volume":"16","author":"Priolo","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2025.101480_bib65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/jmg.2007.053207","article-title":"Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation","volume":"45","author":"Scott","year":"2008","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.gim.2025.101480_bib66","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/ajmg.a.36672","article-title":"Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes","volume":"164A","author":"Emrick","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.0.CO;2-M","article-title":"Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review","volume":"79","author":"Hoyme","year":"1998","journal-title":"Am J Med Genet"},{"issue":"14","key":"10.1016\/j.gim.2025.101480_bib68","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ajmg.a.31323","article-title":"Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies","volume":"140","author":"Shuman","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/BPO.0b013e3182471b04","article-title":"Incidence of abdominal tumors in syndromic and idiopathic hemihypertrophy\/isolated hemihyperplasia","volume":"32","author":"Dempsey-Robertson","year":"2012","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib70","first-page":"417","article-title":"Results of fifteen-year follow-up from a single center: findings and risks for tumor development in isolated hemihyperplasia cases","volume":"25","author":"Atik","year":"2014","journal-title":"Genet Couns"},{"issue":"6","key":"10.1016\/j.gim.2025.101480_bib71","first-page":"405","article-title":"Isolated lateralized overgrowth: clinical, radiological, and auxological characteristics of a single-site cohort of 76 cases","volume":"120","author":"Romaris","year":"2022","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.gim.2025.101480_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.613260","article-title":"Characterization and childhood tumor risk assessment of genetic and epigenetic syndromes associated with lateralized overgrowth","volume":"8","author":"Griff","year":"2020","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.gim.2025.101480_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000355544","article-title":"Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance","volume":"80","author":"Brioude","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"10.1016\/j.gim.2025.101480_bib74","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/adc.2006.101295","article-title":"Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice","volume":"91","author":"Scott","year":"2006","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.gim.2025.101480_bib75","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ajmg.a.37881","article-title":"Tumor screening in Beckwith-Wiedemann syndrome-To screen or not to screen?","volume":"170","author":"Kalish","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.gim.2025.101480_bib76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/adc.87.3.241","article-title":"Controversies and advances in the management of Wilms\u2019 tumour","volume":"87","author":"Pritchard-Jones","year":"2002","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.gim.2025.101480_bib77","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10897-017-0182-8","article-title":"Tumor screening in Beckwith-Wiedemann syndrome: parental perspectives","volume":"27","author":"Duffy","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.gim.2025.101480_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpeds.2019.05.051","article-title":"Development of the serum alpha-fetoprotein reference range in patients with Beckwith-Wiedemann spectrum","volume":"212","author":"Duffy","year":"2019","journal-title":"J Pediatr"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:29:35Z","timestamp":1790825375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1098360025001273"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101480","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated lateralized overgrowth and the need for tumor screening: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101480"}}